Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance With Age; the Role of Amino Acids in Modulating Muscle Metabolism
NCT ID: NCT01735539
Last Updated: 2014-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2011-12-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators plan to supplement the feed with arginine, a safe and widely found non-essential amino acid, to explore if this can improve muscle blood flow.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modulation of Muscle Protein Metabolism by Essential Amino Acids
NCT01890369
Protein Source on Plasma Amino Acid Concentrations In Older Adults
NCT04243395
Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly
NCT00557388
Amino Acid Bioavailability in Healthy Elderly After Intake of an Oral Nutritional Supplement
NCT02013466
Determination of the UL of Leucine in Healthy Elderly Men
NCT02095080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There is sexual dimorphism thus initially we will just recruit males. Powering calculations dictate n=8 in each group.
We will use well established stable isotope tracer techniques (with 13C6 Phenylalanine) to measure muscle protein synthesis and breakdown by Gas Chromatography - combustion - isotope ratio mass spectroscopy.
We will measure leg blood flow by phase shift Doppler and muscle microvascular flow by contrast enhanced ultrasound.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Old Bolus
15g EAA bolus
15g EAA bolus
Oral; in aqueous solution
Old Arginine
15g EAA Bolus supplemented with 3g Arginine
15g EAA Bolus supplemented with 3g Arginine
Oral; in aqueous solution
Young Bolus
15g EAA bolus
15g EAA bolus
Oral; in aqueous solution
Young Pulse
4 x 3.75g Mixed EAA Pulses
4 x 3.75g Mixed EAA Pulses
Oral; in aqueous solution
Old Pulse
4 x 3.75g Mixed EAA Pulses
4 x 3.75g Mixed EAA Pulses
Oral; in aqueous solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
15g EAA bolus
Oral; in aqueous solution
4 x 3.75g Mixed EAA Pulses
Oral; in aqueous solution
15g EAA Bolus supplemented with 3g Arginine
Oral; in aqueous solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetes
* Beta blocker or steroid use
* Established cerebrovascular, peripheral vascular or ischaemic heart disease.
18 Years
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip J Atherton, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Nottingham School of Graduate Entry Medicine and Health
Derby, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mitchell WK, Phillips BE, Williams JP, Rankin D, Lund JN, Smith K, Atherton PJ. A dose- rather than delivery profile-dependent mechanism regulates the "muscle-full" effect in response to oral essential amino acid intake in young men. J Nutr. 2015 Feb;145(2):207-14. doi: 10.3945/jn.114.199604. Epub 2014 Dec 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UNottingham F/3/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.